Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2011 - 2015)

Vanda Pharmaceuticals has disclosed Other Non-Current Assets across 5 years of filings, most recently posting $813000.0 for Q3 2015.

• Other Non-Current Assets for Q3 2015 came in at $813000.0, up 3.57% year-over-year; the trailing twelve-month figure through Sep 2015 was $813000.0 (up 3.57% YoY), and the FY2014 annual result was $813000.0, up 62.6% from the prior year.
• Other Non-Current Assets came in at $813000.0 for Q3 2015 at Vanda Pharmaceuticals, roughly flat from $813000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q3 2011 to a low of $84000.0 in Q1 2012.
• The 5-year median for Other Non-Current Assets is $692500.0 (2011), against an average of $682277.8.
• Across the five-year window, Other Non-Current Assets tumbled 41.75% in 2012 and jumped 614.29% in 2013, its largest moves.
• Vanda Pharmaceuticals' Other Non-Current Assets stood at $600000.0 in 2011, then changed by 0.0% to $600000.0 in 2012, then dropped by 16.67% to $500000.0 in 2013, then jumped by 62.6% to $813000.0 in 2014, then changed by 0.0% to $813000.0 in 2015.
• The last three Other Non-Current Assets figures came in at $813000.0 (Q3 2015), $813000.0 (Q2 2015), and $813000.0 (Q1 2015), per Business Quant data.